FibroBiologics, Inc. (FBLG) Stock
FibroBiologics stock price chart
FBLG stock quote & key statistics
FibroBiologics annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2026 | $0 | -$18.6M | -$5.19 |
| FY2025 | $0 | -$11.2M | -$3.21 |
| FY2024 | $0 | -$16.5M | $0.33 |
| FY2023 | $0 | -$5.1M | — |
| FY2022 | $0 | -$1.6M | — |
Fiscal year ending June 30. Source: company filings via EODHD.
About FibroBiologics, Inc.
FibroBiologics, Inc. is a pioneering cell therapy and regenerative medicine company dedicated to advancing treatments and potential cures for chronic diseases. Leveraging fibroblast cells and fibroblast-derived materials, the company is at the forefront of developing a robust pipeline aimed at addressing diverse medical conditions.
With a strong focus on innovation, FibroBiologics holds over 150 U.S. and international patents, with additional patents pending. These patents span various clinical pathways including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, organ involution reversal, and cancer treatment.
Founded in 2021 and headquartered in Houston, Texas, FibroBiologics is positioned at the intersection of cutting-edge research and therapeutic development. The company's commitment to pioneering regenerative therapies underscores its mission to significantly impact patient care and outcomes across a broad spectrum of chronic diseases.
FibroBiologics stock FAQ
What is the FibroBiologics stock ticker symbol?
FibroBiologics, Inc. trades on the NASDAQ under the ticker symbol FBLG.
What sector and industry is FibroBiologics in?
FibroBiologics, Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does FibroBiologics have?
FibroBiologics, Inc. has about 15 full-time employees.
What were FibroBiologics's revenue and earnings last fiscal year?
FibroBiologics reported revenue of $0 and net income of -$18.6M in fiscal 2026, with earnings per share of -$5.19.
When did FibroBiologics go public?
FibroBiologics stock began trading on January 31, 2024.
Biotechnology stocks
All Healthcare stocks →- ACADACADIA Pharmaceuticals
- ALNYAlnylam
- ARWRArrowhead Pharmaceuticals
- ASNDAscendis Pharma A/S
- BMRNBioMarin Pharmaceutical
- CAICaris Life Sciences
- CORTCorcept Therapeutics
- EXELExelixis
- FTREFortrea
- HALOHalozyme Therapeutics
- HRMYHarmony Biosciences
- INCYIncyte
- IONSIonis Pharmaceuticals
- JAZZJazz Pharmaceuticals
- MDGLMadrigal Pharmaceuticals
- MRNAModerna
- NVAXNovavax
- PTCTPTC Therapeutics
- RAREUltragenyx Pharmaceutical
- REGNRegeneron
- RPRXRoyalty Pharma
- SRPTSarepta Therapeutics
- TECHBio-Techne
- VRTXVertex